Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
George, D. J.
Morgans, A. K.
Abrahm, J. L.
Davis, I. D.
Fitch, M. I.
Millar, J. L.
O'Sullivan, J. M.
Evans, S. M.
AffiliationSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
MetadataShow full item record
AbstractBackground There is variation in the care provided to men with metastatic prostate cancer (mPCa). There has been no previous set of quality indicators (QIs) regarding the management of men with mPCa. The objective of this study is to develop a set of international mPCa-specific QIs, which will enable global benchmarking of quality of care. Materials and methods Potential QIs were identified through a literature review. Fourteen multidisciplinary mPCa experts (representing medical and radiation oncology, nursing, psychology, palliative care and urology) from eight countries participated in a modified Delphi process, which consisted of two online surveys, one face-to-face meeting and two teleconferences. Panelists were asked to rate each indicator's importance and feasibility on a Likert scale from 1 to 9. Indicators that received median importance and median feasibility scores ≥ 7.5, and a disagreement index <1 for both measures, on the final round of voting were included in the final set. Results There was consensus on 23 QIs out of total of 662. Four regarding “general management”, 12 “therapies”, three “complications” and four “patient-reported quality of life”. One of the inherent limitations of the Delphi process is that there is a small expert panel involved. Conclusion The quality indicator set defined by our process for management of men with mPCa will enable greater understanding of the standard and variation of care globally and will promote consistency of good practice. Future directions will include retrospective evaluation for compliance with these indicators, as well as prospective monitoring.
CitationZheng J, Sampurno F, George DJ, Morgans AK, Nguyen H, Abrahm JL, et al. Establishing metastatic prostate cancer quality indicators using a modified Delphi approach. Vol. 20, Clinical Genitourinary Cancer. Elsevier BV; 2022. p. e151–7.
JournalClinical Genitourinary Cancer
TypeMeetings and Proceedings